Comparison of the Impact of Metformin and Calcitropin in Treating Polycystic Ovaries in Infertile Wome

Phase 3

• Conditions: Condition 1: Polycystic ovaries, infertility. Condition 2: Infertility.; Polycystic ovarian syndrome; Female infertility, unspecified; E28.2; N97.9

• Registration Number: IRCT20140422017388N3
• Lead Sponsor: Hakim Razi azar

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Women aged 20-45 years
I.e., first pregnancy, oliguria or menstrual disorders, clinical signs such as hyperandrogenism, no history of drug use for menstrual disorders in the last three months without any signs of infertility
No male factor in the partner

Exclusion Criteria

Absence of inclusion criteria

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Infertile women with polycystic ovaries. Timepoint: Three months after taking the drug. Method of measurement: Sonography.